Trial Profile

Prevention of New Onset Diabetes After Transplantation by a Short Term Treatment of Vildagliptin in the Early Post-transplant Period

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 19 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vildagliptin (Primary)
Indications Diabetes mellitus
Focus Adverse reactions
Acronyms PRODIG

Most Recent Events

01 Aug 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2024.
01 Aug 2022 Planned primary completion date changed from 1 Jul 2021 to 1 Jul 2024.
01 Feb 2021 Planned End Date changed from 1 Oct 2020 to 1 Dec 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com